The role of polyfunctional T cells in infection control

doi:10.3969/j.issn.1673-8640.2014.10.019

Abstract

Abstract:

Polyfunctional T cells can secrete a variety of cytokines and have the ability of proliferation, which are strong in the control of chronic infection. The quality of T cell response has a key role in the prognosis of a variety of infectious diseases. Understanding the different T cell subsets, especially the changes of antigen-specific T cell subsets in amount and function, it is crucial for the diagnosis and prognosis of infectious diseases and for the design of various infections and cancer preventive or therapeutic vaccine.

Key words: Polyfunctional T cell, Cytokine, Infection control

CLC Number:

R446.63

QIAO Dan, WU Wenjuan. The role of polyfunctional T cells in infection control[J]. , 2014, 29(10): 1059-1063.

References

[1] Makedonas G, Betts MR. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection[J]. Springer Semin Immunopathol, 2006, 28(3):209-219.
[2] 李丽, 吴长有. 多功能T 细胞的检测及其意义[J]. 中国免疫学杂志, 2009, 25 (2): 99-102.
[3] De Rosa SC, Herzenberg LA, Herzenberg LA, et al. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity [J]. Nat Med, 2001, 7 (2):245-248.
[4] 吴长有. 初始和记忆T 细胞的研究进展[J]. 现代免疫学, 2005, 25 (5): 353-356.
[5] Betts MR, Nason MC, West SM, et al. HIV non-progressors preferentially maintain highly functional HIV-specific CD8(+) T cells [J]. Blood, 2006,107 (12): 4781-4789.
[6] Gómez CE, Perdiguero B, Garcia-Arriaza J, et al. Poxvirus vectors as HIV/AIDS vaccines in humans[J]. Hum Vaccin Immunother, 2012, 8 (9):1192-1207.
[7] Barnaba V. Tuning cross-presentation of apoptotic T cells in immunopathology[J]. Adv Exp Med Biol, 2013, 785:27-35.
[8] Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unravelling the immune system [J]. Nat Rev Immunol, 2004, 4 (8): 648-655.
[9] Darrah PA, Patel DT, De Luca PM, et al. Multi-functional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major [J]. Nat Med, 2007, 13 (7): 843-850.
[10] Precopio ML, Betts MR, Parrino J, et al. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses [J]. J Exp Med, 2007, 204 (6): 1405-1416.
[11] Kannanganat S, Ibegbu C, Chennareddi L, et al. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells [J]. J Virol, 2007, 81 (16): 8468-8476.
[12] Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease [J]. Nat Med, 2004, 10 (4): 406-410.
[13] Basu Roy R, Whittaker E, Kampmann B. Current understanding of the immune response to tuberculosis in children[J]. Curr Opin Infect Dis, 2012, 25(3):250-257.
[14] Yu H, Jiang X, Shen C, et al. Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4(+) T cells[J]. Infect Immun, 2010, 78(5): 2272-2282.
[15] Sauzullo I, Mengoni F, Marocco R, et al. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis [J]. Br J Dermatol, 2013, 169(5):1133-1140.
[16] Betts MR, Brenchley JM, Price DA, et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation [J]. J Immunol Methods, 2003, 281 (1-2): 65-78.
[17] Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection [J]. J Virol, 2001, 75 (24): 11983-11991.
[18] Palladino C, Briz V, Bellón JM, et al. Predictors of attrition and immunological failure in HIV-1 patients on highly active antiretroviral therapy from different healthcare settings in Mozambique[J]. PLoS One, 2013, 8(12):e82718.
[19] Tully G, Kortsik C, Höhn H, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection [J]. J Immunol, 2005, 174 (4): 2174-2184.
[20] Brookes RH, Pathan AA, McShane H, et al. CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages [J]. Eur J Immunol, 2003, 33 (12): 3293-3302.
[21] Wilkinson KA, Wilkinson RJ, Pathan A, et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis [J]. Clin Infect Dis, 2005, 40 (1): 184-187.
[22] Lammas DA, De Heer E, Edgar JD, et al. Hetero-geneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway [J]. Int J Exp Pathol, 2002, 83 (1): 1-20.
[23] Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent [J]. N Engl J Med, 2001, 345 (15): 1098-1104.
[24] Kalsdorf B, Scriba TJ, Wood K, et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria [J]. Am J Respir Crit Care Med, 2009, 180 (12): 1262-1270.
[25] Caccamo N, Guggino G, Joosten SA, et al. Multi-functional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection [J]. Eur J Immunol, 2010, 40 (8): 2211-2220.
[26] Beveridge NE, Price DA, Casazza JP, et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis -specific CD4+ memory T lymphocyte populations [J]. Eur J Immunol, 2007, 37 (11): 3089-3100.
[27] Emu B, Sinclair E, Favre D, et al. Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment [J]. J Virol, 2005,79 (22): 14169-14178.
[28] Iyasere C, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2 [J]. J Virol, 2003, 77 (20): 10900-10909.
[29] Duvall MG, Precopio ML, Ambrozak DA, et al. Polyfunctional T cell responses are a hallmark of HIV-2 infection [J]. Eur J Immunol, 2008, 38 (2): 350-363.
[30] Ding ZC, Zhou G. Cytotoxic chemotherapy and CD4+ effector T cells: an emerging alliance for durable antitumor effects[J]. Clin Dev Immunol, 2012,2012: 890178.